Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN360514 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Budding Uninhibited By Benzimidazoles 1 Homolog (Yeast) (BUB1) (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references No mutations of the Bub1 gene in human gastric and oral cancer cell lines.
The beta2-adaptin clathrin adaptor interacts with the mitotic checkpoint kinase BubR1.
hBUB1 defects in leukemia and lymphoma cells.
Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.
Expression of hBUB1 in acute myeloid leukemia.
Nakagawa H, Yokozaki H, Oue N, Sugiyama M, Ishikawa T, Tahara E, Yasui W
Oncology reports 2002 Nov-Dec;9(6):1229-32
Oncology reports 2002 Nov-Dec;9(6):1229-32
The beta2-adaptin clathrin adaptor interacts with the mitotic checkpoint kinase BubR1.
Cayrol C, Cougoule C, Wright M
Biochemical and biophysical research communications 2002 Nov 15;298(5):720-30
Biochemical and biophysical research communications 2002 Nov 15;298(5):720-30
hBUB1 defects in leukemia and lymphoma cells.
Ru HY, Chen RL, Lu WC, Chen JH
Oncogene 2002 Jul 11;21(30):4673-9
Oncogene 2002 Jul 11;21(30):4673-9
Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.
Shichiri M, Yoshinaga K, Hisatomi H, Sugihara K, Hirata Y
Cancer research 2002 Jan 1;62(1):13-7
Cancer research 2002 Jan 1;62(1):13-7
Expression of hBUB1 in acute myeloid leukemia.
Lin SF, Lin PM, Yang MC, Liu TC, Chang JG, Sue YC, Chen TP
Leukemia & lymphoma 2002 Feb;43(2):385-91
Leukemia & lymphoma 2002 Feb;43(2):385-91
No comments: Submit comment
No validations: Submit validation data